Not to be Published
ORDER CONCLUDING PROCEEDINGS 1
LAURA D. MILLMAN, Special Master.
On November 15, 2016, petitioner filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that influenza ("flu") and Pneumovax (PPV/23) vaccines administered on November 17, 2013 caused him positive HLA-B27 marker spondyloarthropathy.
On February 16, 2017, petitioner orally made a Motion for Voluntary Dismissal under Vaccine Rule 21(a)(1)(A).
Under Vaccine Rule 21(a)(1)(A), petitioner may engage in a voluntary dismissal by making a motion for dismissal at any time before service of respondent's Rule 4(c) Report, which petitioner has done in the instant action.
Under Vaccine Rule 21(a)(3), the result of this voluntary dismissal is an Order Concluding Proceedings. No judgment will enter pursuant to Vaccine Rule 11 for purposes of 42 U.S.C. § 300aa-21(a).
This petition is